부산대학교 도서관

Wagemakers, R.T.A.; Moors, J.J.A.; Janssens, M.J.B.T.

Wagemakers, R.T.A.; Moors, J.J.A.; Janssens, M.J.B.T.

Tilburg University, School of Economics and Management, Research Memorandum.

Wagemakers, R.T.A.; Moors, J.J.A.; Janssens, M.J.B.T.

Tilburg University, School of Economics and Management, Other publications TiSEM.

Holden RM; Division of Nephrology, Department of Medicine, Queen's University, Kingston, ON, Canada.; Mustafa RA; Division of Nephrology and Hypertension, Department of Internal Medicine, The University of Kansas Medical Center, Kansas City, USA.; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada.; Alexander RT; Department of Pediatrics and Physiology, University of Alberta, Edmonton, Canada.; Battistella M; University Health Network, Leslie Dan Faculty of Pharmacy, University of Toronto, ON, Canada.; Bevilacqua MU; Division of Nephrology, Department of Medicine, The University of British Columbia, Vancouver, Canada.; Knoll G; Division of Nephrology, The Ottawa Hospital, ON, Canada.; Mac-Way F; Division of Nephrology, CHU de Québec, Hôtel-Dieu de Québec Hospital, Université Laval, Québec City, QC, Canada.; Reslerova M; Nephrology Section, St. Boniface General Hospital, University of Manitoba, Winnipeg, Canada.; Wald R; Division of Nephrology, St. Michael's Hospital, University of Toronto, ON, Canada.; Acott PD; Division of Nephrology, Department of Pediatrics, Dalhousie University, Halifax, NS, Canada.; Feltmate P; Department of Geriatric Medicine, Dalhousie University, Halifax, NS, Canada.; Grill A; Department of Family & Community Medicine, University of Toronto, ON, Canada.; Jindal KK; Division of Nephrology, Department of Medicine, University of Alberta, Edmonton, Canada.; Karsanji M; Professional Practice, Vancouver Coastal Health, Richmond, BC, Canada.; Kiberd BA; Division of Nephrology, Department of Medicine, Dalhousie University, Halifax, NS, Canada.; Mahdavi S; Department of Nutritional Sciences, University of Toronto, ON, Canada.; Department of Nephrology, Scarborough Health Network, ON, Canada.; McCarron K; Nova Scotia Renal Program, Nova Scotia Health Authority, Halifax, Canada.; Molnar AO; Division of Nephrology, McMaster University, Hamilton, ON, Canada.; Pinsk M; Division of Nephrology, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Canada.; Rodd C; Division of Diabetes & Endocrinology, Department of Pediatrics & Child Health, University of Manitoba, Winnipeg, Canada.; Soroka SD; Division of Nephrology, Department of Medicine, Dalhousie University, NSHA Renal Program and Pharmacy Services, Halifax, NS, Canada.; Vinson AJ; Division of Nephrology, Dalhousie University, Halifax, NS, Canada.; Zimmerman D; Division of Nephrology, Department of Medicine, University of Ottawa, ON, Canada.; Clase CM; Division of Nephrology, Department of Medicine, Department of Health Research, Evidence and Impact, McMaster University, Hamilton, ON, Canada.

Publisher: SAGE Publications Country of Publication: England NLM ID: 101640242 Publication Model: eCollection Cited Medium: Print ISSN: 2054-3581 (Print) Linking ISSN: 20543581 NLM ISO Abbreviation: Can J Kidney Health Dis Subsets: PubMed not MEDLINE

Erben, R.G.; Silva-Lima, B.; Reischl, I.; Steinhoff, G.; Tiedemann, G.; Dalemans, W.; Vos, A.; Janssen, R.T.A.; Le Blanc, K.; Van Osch, G.J.V.M.; Luyten, F.P.

In: Tissue Engineering - Part A. (Tissue Engineering - Part A, 2014, 20(19-20):2549-2554)

Frenk, L.D.S.; Rahel, B.M.; Prestigiacomo, F.G.; Meeder, J.G.; de Vos, C.B.; van Osch, F.H.M.; Janssen, M.J.W.; Willemsen, R.T.A.; van 'T Hof, A.W.

In: BMJ Open. (BMJ Open, 20 December 2024, 14(12))

Lesch, S.; Blumenberg, V.; Stoiber, S.; Gottschlich, A.; Ogonek, J.; Cadilha, B.L.; Rataj, F.; Dorman, K.; Lutz, J.; Karches, C.H.; Heise, C.; Kurzay, M.; Grassmann, S.; Rapp, M.; Nottebrock, A.; Kruger, S.; Tokarew, N.; Metzger, P.; Hoerth, C.; Benmebarek, M.-R.; Dhoqina, D.; Grünmeier, R.; Seifert, M.; Oener, A.; Umut, Ö.; Huynh, D.; Rothenfusser, S.; König, L.M.; Schnurr, M.; Endres, S.; Kobold, S.; Reischer, A.; Subklewe, M.; Dantes, Z.; Reichert, M.; Larimer, B.M.; Joaquina, S.; Vimeux, L.; Donnadieu, E.; Tran, T.; Tartour, E.; Hank, T.; Baba, T.; Liss, A.S.; Megens, R.T.A.; Hristov, M.; Janssen, K.-P.; Jastroch, M.; Lamp, D.; Ruehland, S.; Di Pilato, M.; Pruessmann, J.N.; Mempel, T.R.; Thomas, M.; Marr, C.; Ormanns, S.; Duewell, P.; Halama, N.

In: Nature Biomedical Engineering. (Nature Biomedical Engineering, November 2021, 5(11):1246-1260)

Fowler EA; Kidney Foundation of Canada, Montreal, QC, Canada.; Bell K; Patient Partner and Member of Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD), Vancouver, BC, Canada.; Burns K; University of Ottawa and the Ottawa Hospital, ON, Canada.; Chiazzese A; Patient Partner and Member of Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD), Vancouver, BC, Canada.; DeSerres SA; Université Laval, Québec, QC, Canada.; Foster BJ; McGill University Health Centre, Montreal, QC, Canada.; Hartwig S; Department of Biomedical Sciences, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, Canada.; Herrington G; Patient Partner and Member of Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD), Vancouver, BC, Canada.; James MT; University of Calgary, AB, Canada.; Jensen V; Simon Fraser University, Vancouver, BC, Canada.; Jones N; University of Guelph, ON, Canada.; Kidston S; Patient Partner and Member of Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD), Vancouver, BC, Canada.; Lemay S; McGill University Health Centre, Montreal, QC, Canada.; Levin A; The University of British Columbia, Vancouver, Canada.; MacPhee A; Patient Partner and Member of Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD), Vancouver, BC, Canada.; McCutcheon S; Patient Partner and Member of Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD), Vancouver, BC, Canada.; Ravani P; University of Calgary, AB, Canada.; Samuel S; University of Calgary, AB, Canada.; Scholey J; University of Toronto, ON, Canada.; Takano T; McGill University Health Centre, Montreal, QC, Canada.; Tangri N; University of Manitoba, Winnipeg, Canada.; Verdin N; Patient Partner and Member of Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD), Vancouver, BC, Canada.; Alexander RT; Department of Pediatrics, University of Alberta, Edmonton, Canada.; Clase CM; Departments of Medicine and Health Research Methods, Evidence and Impact, St Joseph's Healthcare Hamilton, McMaster University, Hamilton, ON, Canada.

Publisher: SAGE Publications Country of Publication: England NLM ID: 101640242 Publication Model: eCollection Cited Medium: Print ISSN: 2054-3581 (Print) Linking ISSN: 20543581 NLM ISO Abbreviation: Can J Kidney Health Dis Subsets: PubMed not MEDLINE

Megens, R.T.A.; Reitsma, S.; Prinzen, L.; Engels, W.; Reesink, K.D.; Slaaf, D.W.; Van Zandvoort, M.A.M.J.; Oude Egbrink, M.G.A.; Leenders, P.J.A.; Janssen, B.J.A.; Brunenberg, E.J.L.; Ter Haar Romeny, B.M.

In: Journal of Biomedical Optics. (Journal of Biomedical Optics, 2010, 15(1))

Wedzicha JA; From the National Heart and Lung Institute, Imperial College London, London (J.A.W.), and the Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester (J.V.) - all in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (D.B., R.T.A., C.T., R.F.); Asthma and Airway Centre, University Health Network and University of Toronto, Toronto (K.R.C.); Service de Pneumologie Assistance Publique-Hôpitaux de Paris, University Paris Descartes (EA2511), Paris (N.R.); Novartis Pharma AG, Basel, Switzerland (F.P.); and the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany (C.F.V.).; Banerji D; From the National Heart and Lung Institute, Imperial College London, London (J.A.W.), and the Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester (J.V.) - all in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (D.B., R.T.A., C.T., R.F.); Asthma and Airway Centre, University Health Network and University of Toronto, Toronto (K.R.C.); Service de Pneumologie Assistance Publique-Hôpitaux de Paris, University Paris Descartes (EA2511), Paris (N.R.); Novartis Pharma AG, Basel, Switzerland (F.P.); and the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany (C.F.V.).; Chapman KR; From the National Heart and Lung Institute, Imperial College London, London (J.A.W.), and the Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester (J.V.) - all in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (D.B., R.T.A., C.T., R.F.); Asthma and Airway Centre, University Health Network and University of Toronto, Toronto (K.R.C.); Service de Pneumologie Assistance Publique-Hôpitaux de Paris, University Paris Descartes (EA2511), Paris (N.R.); Novartis Pharma AG, Basel, Switzerland (F.P.); and the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany (C.F.V.).; Vestbo J; From the National Heart and Lung Institute, Imperial College London, London (J.A.W.), and the Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester (J.V.) - all in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (D.B., R.T.A., C.T., R.F.); Asthma and Airway Centre, University Health Network and University of Toronto, Toronto (K.R.C.); Service de Pneumologie Assistance Publique-Hôpitaux de Paris, University Paris Descartes (EA2511), Paris (N.R.); Novartis Pharma AG, Basel, Switzerland (F.P.); and the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany (C.F.V.).; Roche N; From the National Heart and Lung Institute, Imperial College London, London (J.A.W.), and the Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester (J.V.) - all in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (D.B., R.T.A., C.T., R.F.); Asthma and Airway Centre, University Health Network and University of Toronto, Toronto (K.R.C.); Service de Pneumologie Assistance Publique-Hôpitaux de Paris, University Paris Descartes (EA2511), Paris (N.R.); Novartis Pharma AG, Basel, Switzerland (F.P.); and the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany (C.F.V.).; Ayers RT; From the National Heart and Lung Institute, Imperial College London, London (J.A.W.), and the Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester (J.V.) - all in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (D.B., R.T.A., C.T., R.F.); Asthma and Airway Centre, University Health Network and University of Toronto, Toronto (K.R.C.); Service de Pneumologie Assistance Publique-Hôpitaux de Paris, University Paris Descartes (EA2511), Paris (N.R.); Novartis Pharma AG, Basel, Switzerland (F.P.); and the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany (C.F.V.).; Thach C; From the National Heart and Lung Institute, Imperial College London, London (J.A.W.), and the Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester (J.V.) - all in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (D.B., R.T.A., C.T., R.F.); Asthma and Airway Centre, University Health Network and University of Toronto, Toronto (K.R.C.); Service de Pneumologie Assistance Publique-Hôpitaux de Paris, University Paris Descartes (EA2511), Paris (N.R.); Novartis Pharma AG, Basel, Switzerland (F.P.); and the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany (C.F.V.).; Fogel R; From the National Heart and Lung Institute, Imperial College London, London (J.A.W.), and the Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester (J.V.) - all in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (D.B., R.T.A., C.T., R.F.); Asthma and Airway Centre, University Health Network and University of Toronto, Toronto (K.R.C.); Service de Pneumologie Assistance Publique-Hôpitaux de Paris, University Paris Descartes (EA2511), Paris (N.R.); Novartis Pharma AG, Basel, Switzerland (F.P.); and the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany (C.F.V.).; Patalano F; From the National Heart and Lung Institute, Imperial College London, London (J.A.W.), and the Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester (J.V.) - all in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (D.B., R.T.A., C.T., R.F.); Asthma and Airway Centre, University Health Network and University of Toronto, Toronto (K.R.C.); Service de Pneumologie Assistance Publique-Hôpitaux de Paris, University Paris Descartes (EA2511), Paris (N.R.); Novartis Pharma AG, Basel, Switzerland (F.P.); and the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany (C.F.V.).; Vogelmeier CF; From the National Heart and Lung Institute, Imperial College London, London (J.A.W.), and the Centre for Respiratory Medicine and Allergy, University of Manchester and University Hospital South Manchester NHS Foundation Trust, Manchester (J.V.) - all in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (D.B., R.T.A., C.T., R.F.); Asthma and Airway Centre, University Health Network and University of Toronto, Toronto (K.R.C.); Service de Pneumologie Assistance Publique-Hôpitaux de Paris, University Paris Descartes (EA2511), Paris (N.R.); Novartis Pharma AG, Basel, Switzerland (F.P.); and the Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-Universität Marburg, Marburg, Germany (C.F.V.).

Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE